Find Rucaparib Camsylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

99 RELATED EXCIPIENT COMPANIES

160EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1859053-21-6, Rucaparib (camsylate), Rucaparib (monocamsylate), Pf-1367338-bw, C0-338, [(1s,4r)-7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl]methanesulfonic acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
Molecular Formula
C29H34FN3O5S
Molecular Weight
555.7  g/mol
InChI Key
INBJJAFXHQQSRW-STOWLHSFSA-N
FDA UNII
41AX9SJ8KO

Rucaparib Camsylate
Rucaparib Camsylate is the camsylate salt form of rucaparib, an orally bioavailable tricyclic indole and inhibitor of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1, 2 and 3 and inhibits PARP-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes genomic instability and induces cell cycle arrest and apoptosis. This may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. PARPs are enzymes activated by single-strand DNA breaks that catalyze the post-translational ADP-ribosylation of nuclear proteins, which induces signaling and the recruitment of other proteins to repair damaged DNA. The PARP-mediated repair pathway plays a key role in DNA repair and is dysregulated in a variety of cancer cell types.
1 2D Structure

Rucaparib Camsylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(1S,4R)-7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl]methanesulfonic acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
2.1.2 InChI
InChI=1S/C19H18FN3O.C10H16O4S/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15;1-9(2)7-3-4-10(9,8(11)5-7)6-15(12,13)14/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24);7H,3-6H2,1-2H3,(H,12,13,14)/t;7-,10-/m.1/s1
2.1.3 InChI Key
INBJJAFXHQQSRW-STOWLHSFSA-N
2.1.4 Canonical SMILES
CC1(C2CCC1(C(=O)C2)CS(=O)(=O)O)C.CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2
2.1.5 Isomeric SMILES
CC1([C@@H]2CC[C@]1(C(=O)C2)CS(=O)(=O)O)C.CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2
2.2 Other Identifiers
2.2.1 UNII
41AX9SJ8KO
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1859053-21-6

2. Rucaparib (camsylate)

3. Rucaparib (monocamsylate)

4. Pf-1367338-bw

5. C0-338

6. [(1s,4r)-7,7-dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl]methanesulfonic Acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one

7. Co-338

8. 41ax9sj8ko

9. Rucaparib Camsylate [usan]

10. Bicyclo(2.2.1)heptane-1-methanesulfonic Acid, 7,7-dimethyl-2-oxo-, (1s,4r)-, Compd. With 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-6h-pyrrolo(4,3,2-ef)(2)benzazepin-6-one (1:1)

11. Bicyclo[2.2.1]heptane-1-methanesulfonic Acid, 7,7-dimethyl-2-oxo-, (1s,4r)-, Compd. With 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6h-pyrrolo[4,3,2-ef][2]benzazepin-6-one (1:1)

12. Rucaparib(camsylate)

13. Ag14699 Camsylate

14. Rucaparib Camphosulfonate

15. Rucaparib Camphorsulfonate

16. Chembl3833368

17. Rucaparib Camsylate [mi]

18. Schembl22817574

19. Amy9250

20. Chebi:134692

21. Dtxsid301027866

22. 8-fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6h-pyrrolo(4,3,2-ef)(2)benzazepin-6-one (7,7-dimethyl-2-oxobicyclo(2.2.1)heptan-1-yl)methanesulfonate (1:1)

23. Bcp18101

24. Ex-a3053

25. Rucaparib Camsylate [who-dd]

26. S5195

27. Cs-6939

28. Rucaparib Camsylate [orange Book]

29. Ac-30110

30. Hy-102003

31. A902311

32. Q27258428

33. ((1s,4r)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic Acid - 8-fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one (1:1)

34. [4-(8-fluoro-6-oxo-3,4,5,6-tetrahydro-1h-azepino[5,4,3-cd]indol-2-yl)phenyl]-n-methylmethanaminium [(1s,4r)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl]methanesulfonate

35. 8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1h-azepino[5,4,3-cd]indol-1-one ((1s,4r)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate

2.3.2 Other Synonyms

1. 283173-50-2

2. Rubraca

3. Rucaparib

4. 8237f3u7eh

2.4 Create Date
2016-08-16
3 Chemical and Physical Properties
Molecular Weight 555.7 g/mol
Molecular Formula C29H34FN3O5S
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass555.22032053 g/mol
Monoisotopic Mass555.22032053 g/mol
Topological Polar Surface Area137 Ų
Heavy Atom Count39
Formal Charge0
Complexity869
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 1  
Drug NameRUBRACA
Active IngredientRUCAPARIB CAMSYLATE
CompanyCLOVIS ONCOLOGY INC (Application Number: N209115. Patents: 6495541, 7351701, 7531530, 8071579, 8143241, 8754072, 8859562, 9045487, 9861638)

4.2 Drug Indication

Treatment of fallopian tube cancer , Treatment of ovarian cancer , Treatment of primary peritoneal cancer , Treatment of prostate malignant neoplasms


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"RUCAPARIB CAMSYLATE","year":"2021","qtr":"Q2","strtotime":1617561000,"product":"S-RUCAPARIB CAMSYLATE(GROUP-B )(TAX INV NO:1905205314 DT:23.03.2021","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"GAVA AIRFARM LOGISTICS ","customerCountry":"UNITED ARAB EMIRATES","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"19846.2","totalValueFC":"76826.6","currency":"USD","unitRateINR":1429917,"date":"05-Apr-2021","totalValueINR":"5719668","totalValueInUsd":"76826.6","indian_port":"HYDERABAD AIR","hs_no":"29337900","bill_no":"9895510","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1650911400,"product":"RUCAPARIB CAMSYLATE (OTHER)(LUT (ARN)NO","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"HAMBURG - FUHLSBUETT","customer":"AIUEG","customerCountry":"GERMANY","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"23760","totalValueFC":"5937.8","currency":"USD","unitRateINR":1792000,"date":"26-Apr-2022","totalValueINR":"448000","totalValueInUsd":"5937.8","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"9977090","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1654453800,"product":"RUCAPARIB CAMSYLATE","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"TTY BIOPHARM CO LTD","customerCountry":"TAIWAN","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"25000","totalValueFC":"435.8","currency":"USD","unitRateINR":1700000,"date":"06-Jun-2022","totalValueINR":"34000","totalValueInUsd":"435.8","indian_port":"HYDERABAD AIR","hs_no":"29337990","bill_no":"1923806","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709145000,"product":"RUCAPARIB CAMSYLATE (TAX INV.# MH1160000580 DT:22.02.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MADRID","customer":"BSD PHARMA LOG","customerCountry":"SPAIN","quantity":"6.60","actualQuantity":"6.6","unit":"KGS","unitRateFc":"13500","totalValueFC":"88071.9","currency":"USD","unitRateINR":1107221.5454545456,"date":"29-Feb-2024","totalValueINR":"7307662.2","totalValueInUsd":"88071.9","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"7959950","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"407\/408,SHARDA CHAMBERS,, MUMBAI, MAHARASHTRA.","customerAddress":""}]
05-Apr-2021
29-Feb-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Lubricants & Glidants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Coloring Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Rucaparib Camsylate Manufacturers

A Rucaparib Camsylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rucaparib Camsylate, including repackagers and relabelers. The FDA regulates Rucaparib Camsylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rucaparib Camsylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Rucaparib Camsylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Rucaparib Camsylate Suppliers

A Rucaparib Camsylate supplier is an individual or a company that provides Rucaparib Camsylate active pharmaceutical ingredient (API) or Rucaparib Camsylate finished formulations upon request. The Rucaparib Camsylate suppliers may include Rucaparib Camsylate API manufacturers, exporters, distributors and traders.

click here to find a list of Rucaparib Camsylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Rucaparib Camsylate USDMF

A Rucaparib Camsylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Rucaparib Camsylate active pharmaceutical ingredient (API) in detail. Different forms of Rucaparib Camsylate DMFs exist exist since differing nations have different regulations, such as Rucaparib Camsylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Rucaparib Camsylate DMF submitted to regulatory agencies in the US is known as a USDMF. Rucaparib Camsylate USDMF includes data on Rucaparib Camsylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rucaparib Camsylate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Rucaparib Camsylate suppliers with USDMF on PharmaCompass.

Rucaparib Camsylate WC

A Rucaparib Camsylate written confirmation (Rucaparib Camsylate WC) is an official document issued by a regulatory agency to a Rucaparib Camsylate manufacturer, verifying that the manufacturing facility of a Rucaparib Camsylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rucaparib Camsylate APIs or Rucaparib Camsylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Rucaparib Camsylate WC (written confirmation) as part of the regulatory process.

click here to find a list of Rucaparib Camsylate suppliers with Written Confirmation (WC) on PharmaCompass.

Rucaparib Camsylate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rucaparib Camsylate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Rucaparib Camsylate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Rucaparib Camsylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Rucaparib Camsylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rucaparib Camsylate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Rucaparib Camsylate suppliers with NDC on PharmaCompass.

Rucaparib Camsylate GMP

Rucaparib Camsylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Rucaparib Camsylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rucaparib Camsylate GMP manufacturer or Rucaparib Camsylate GMP API supplier for your needs.

Rucaparib Camsylate CoA

A Rucaparib Camsylate CoA (Certificate of Analysis) is a formal document that attests to Rucaparib Camsylate's compliance with Rucaparib Camsylate specifications and serves as a tool for batch-level quality control.

Rucaparib Camsylate CoA mostly includes findings from lab analyses of a specific batch. For each Rucaparib Camsylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Rucaparib Camsylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Rucaparib Camsylate EP), Rucaparib Camsylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rucaparib Camsylate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty